Deka Bank Deutsche Girozentrale Atai Life Sciences N.V. Transaction History

Deka Bank Deutsche Girozentrale

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	BUY	$3.03 - $5.32 $249,974 - $438,900	82,500 New	82,500 $299,000
Q1 2022 Apr 28, 2022	SELL	$4.66 - $7.66 $349,500 - $574,500	-75,000 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$6.82 - $17.8 $511,500 - $1.34 Million	75,000 New	75,000 $558,000

12.4M

77.8K

50.3K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $197M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.